Nipro Corp (8086):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nipro Corp (8086) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3445
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It also offers contract manufacturing services of injection, oral and external use drug formulations. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia, and Africa. Nipro is headquartered in Osaka, Japan.

Nipro Corp (8086) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nipro Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nipro Corp, Medical Devices Deals, 2012 to YTD 2018 9
Nipro Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nipro Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
Nipro Invests US$25 Million In Infraredx 12
Partnerships 13
TC Biopharm and Nipro Enter into Co-Development Partnership 13
Cerus Enters Into Co-Development Agreement With Nipro 14
Sandoz Enters Into Co-promotion Agreement With Nipro Pharma For Somatropin BS S.C. Injection 5mg/10mg [Sandoz] 15
Licensing Agreements 16
Nipro Enters into Licensing Agreement with Sapporo Medical University 16
Acquisition 17
Nipro Acquires Tanabe Seiyaku Hanbai from Mitsubishi Tanabe Pharma 17
Nipro to Acquire Infraredx 18
Mitsubishi Tanabe To Acquire Remaining 49% Stake In Bipha From Nipro 19
Nipro Acquires MGlas And MG Sterile Products For US$34 Million 20
Nipro Corp – Key Competitors 21
Nipro Corp – Key Employees 22
Nipro Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Nipro Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nipro Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nipro Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Nipro Corp, Medical Devices Deals, 2012 to YTD 2018 9
Nipro Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TC BioPharm Raises More Than USD7.8 Million in Series A Financing Round 11
Nipro Invests US$25 Million In Infraredx 12
TC Biopharm and Nipro Enter into Co-Development Partnership 13
Cerus Enters Into Co-Development Agreement With Nipro 14
Sandoz Enters Into Co-promotion Agreement With Nipro Pharma For Somatropin BS S.C. Injection 5mg/10mg [Sandoz] 15
Nipro Enters into Licensing Agreement with Sapporo Medical University 16
Nipro Acquires Tanabe Seiyaku Hanbai from Mitsubishi Tanabe Pharma 17
Nipro to Acquire Infraredx 18
Mitsubishi Tanabe To Acquire Remaining 49% Stake In Bipha From Nipro 19
Nipro Acquires MGlas And MG Sterile Products For US$34 Million 20
Nipro Corp, Key Competitors 21
Nipro Corp, Key Employees 22
Nipro Corp, Other Locations 23
Nipro Corp, Subsidiaries 23
Nipro Corp, Joint Venture 25

List of Figures
Nipro Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nipro Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nipro Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nipro Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nipro Corp (8086):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nord Gold SE:戦略・SWOT・企業財務分析
    Nord Gold SE - Strategy, SWOT and Corporate Finance Report Summary Nord Gold SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • HUP-Zagreb d.d.:企業の戦略・SWOT・財務情報
    HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report Summary HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Braile Biomedica Ltda:製品パイプライン分析
    Summary Braile Biomedica Ltda (Braile Biomedica) is a medical device company that develops biological, cardiovascular, electromechanical, endovascular, and oncology products. The company’s cardiovascular products comprise wirewound arterial cannula, anterograde cardioplegia cannula, wirewound venous …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Afianzadora Latinoamericana Cia de Seguros S.A.:企業の戦略・SWOT・財務情報
    Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Capita plc:企業の戦略・SWOT・財務情報
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • IREN SpA (IRE):企業の財務・戦略的SWOT分析
    IREN SpA (IRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • SunPower Corporation:企業の戦略・SWOT・財務分析
    SunPower Corporation - Strategy, SWOT and Corporate Finance Report Summary SunPower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Norinchukin Bank:企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Giant Eagle, Inc.:企業の戦略・SWOT・財務情報
    Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report Summary Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Walgreens Boots Alliance, Inc.:企業の戦略・SWOT・財務情報
    Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kolon Life Science Inc (102940):製薬・医療:M&Aディール及び事業提携情報
    Summary Kolon Life Science Inc (KLS) focuses on research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, the first cell-mediated gene …
  • Synthetic Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company offers DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages. It offers solutions in genomics research, bioproduction, a …
  • Prinzhorn Holding Gmbh
    Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report Summary Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Societe Generale S.A.:戦略・SWOT・企業財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sobha Ltd:企業の戦略・SWOT・財務情報
    Sobha Ltd - Strategy, SWOT and Corporate Finance Report Summary Sobha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Far East Consortium International Ltd:企業の戦略・SWOT・財務情報
    Far East Consortium International Ltd - Strategy, SWOT and Corporate Finance Report Summary Far East Consortium International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Pro Petroleum Inc:企業の戦略的SWOT分析
    Pro Petroleum Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Rodos BioTarget GmbH (RBT) is a biopharmaceutical company that develops drug delivery platforms. The company provides products such as targosphere, targobiotics and targovir. Its targosphere finds application in treating various infectious diseases such as virus caused HCV and hepatitis c an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆